C27H29N5O3
471.5 g/mol
APIDanger
Zanubrutinib
CAS1691249-45-2
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Zanubrutinib is a pharmaceutical raw material used in the manufacturing of anticancer medications. It functions as a Bruton's tyrosine kinase (BTK) inhibitor and is administered orally.
pharmaceutical raw material for cancer therapyBTK inhibitor compound
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1691249-45-2
Related Compounds
ReferenceSame Category
Insulin detemir
CAS169148-63-4
pharmaceutical raw material
ReferenceSame Category
1beta-maxacalcitol
CAS169218-34-2
pharmaceutical raw material
ReferenceSame Category
Rac Nebivolol hydrochloride
CAS169293-50-9
pharmaceutical raw material
ReferenceSame Category
Parapropamol
CAS1693-37-4
pharmaceutical raw material
Referencestereoisomer of
((plusmn))-Zanubrutinib
CAS1633350-06-7
pharmaceutical raw material
Referencestereoisomer of
(R)-Zanubrutinib
CAS1691249-44-1
pharmaceutical raw material
Referencesame scaffold
(7S)-4,5,6,7-Tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile
CAS2190506-59-1
pharmaceutical intermediate
Safety Reference
Danger
H360May damage fertility or the unborn child
Identifiers
IUPAC Name
(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
InChIKey
RNOAOAWBMHREKO-QFIPXVFZSA-N
SMILES
C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N
Synonyms (21)
- Zanubrutinib (JAN/USAN/INN)
- 1691249-45-2 (S-isomer)
- BGB-3111(Zanubrutinib)?
- BTK-InhB
- Brukinsa
- Brukinsa (TN)
- US20250340560, Compound 27b
- US9447106, 27b (peak 2)
- Zanubrutinib
- Zanubrutinib (BGB-3111)
- Zanubrutinib (Standard)
- compound 27b
- zanubrutinibum